Continuing to up its enforcement game, the Federal Trade Commission (FTC) issued a proposed order to stop two companies from continuing to promote and sell supplements after using baseless health claims. While this order is not finalized and does not include any direct sellers, it is yet another regulatory action to watch.
According to the press release concerning supplement companies:
Two Texas-based companies and their owner are banned from advertising or selling dietary supplements, and from making claims that their products treat, cure, or reduce the risk of disease, under a proposed settlement with the Federal Trade Commission.
The action announced today stems from an administrative complaint the FTC filed in November 2020 against Health Research Laboratories, LLC, Whole Body Supplements, LLC, and their owner and officer Kramer Duhon. The complaint alleged the respondents made unsubstantiated claims that their supplements — The Ultimate Heart Formula (UHF), BG18, and Black Garlic Botanicals — prevent or treat cardiovascular and other diseases, and that their supplement Neupathic cures, mitigates, or treats diabetic neuropathy.
“This order banning the respondents from the supplement industry should put an end to their long history of making baseless claims that their products can treat various diseases,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “People with serious health concerns should rely on their health professionals, not advertisements.”